Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Exploring the incidence of inadequate response to antidepressants in the primary care of depression.

Abrahams AB. et al, (2024), Eur Neuropsychopharmacol, 83, 61 - 70

Hypersexuality in bipolar disorder: an overlooked symptom.

Dolman C. et al, (2024), Lancet Psychiatry, 11, 405 - 406

Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects

E-Wen McCulloch D. et al, (2024), Neuroscience Applied, 3

Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.

Goodwin GM. et al, (2024), Am J Psychiatry, 181, 79 - 81

The psychedelic experience and treatment-resistant depression.

Goodwin GM., (2023), World Psychiatry, 22, 420 - 422

Must Psilocybin Always "Assist Psychotherapy"?

Goodwin GM. et al, (2023), Am J Psychiatry

Psilocybin for Treatment-Resistant Depression. Reply.

Goodwin GM. et al, (2023), N Engl J Med, 388

Unblinding and demand characteristics in the treatment of depression.

Goodwin GM. et al, (2023), J Affect Disord, 328, 1 - 5

Load More